SCHEMBL2174709

SCHEMBL2174709

CO[Si](CC(CN)C(C)N)(OC)OC.[SiH4]

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL114178 0.98 ALDH1A1 (0.33) ALDH1A1
Alcohol SCHEMBL28395342 0.90
SCHEMBL4096619 0.80
SCHEMBL3792471 0.78 ALDH1A1 (0.32) ALDH1A1
SCHEMBL483479 0.77 ALDH1A1 (0.31) ALDH1A1
SCHEMBL28389565 0.77 ALDH1A1 (0.31) ALDH1A1
SCHEMBL1180326 0.77
SCHEMBL14432691 0.77
SCHEMBL29112896 0.76
SCHEMBL29178233 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7973121-B2 Method of preparing polyorganosiloxane with functional groups in the presence of lithium silanolate BLUESTAR SILICONES FRANCE SAS (FR) 2011-07-05 US disclosed
EP-1844088-B1 METHOD OF PREPARING POLYORGANOSILOXANE WITH FUNCTIONAL GROUPS IN THE PRESENCE OF LITHIUM SILANOLATE BLUESTAR SILICONES FRANCE (FR) 2010-01-27 EP disclosed
US-20090099322-A1 Method of Preparing Polyorganosiloxane With Functional Groups In The Presence of Lithium Silanolate RHODIA CHIMIE (FR) 2009-04-16 US disclosed
EP-1844088-A1 METHOD OF PREPARING POLYORGANOSILOXANE WITH FUNCTIONAL GROUPS IN THE PRESENCE OF LITHIUM SILANOLATE Bluestar Silicones France SAS (FR) 2007-10-17 EP disclosed
WO-2006061503-A1 METHOD OF PREPARING POLYORGANOSILOXANE WITH FUNCTIONAL GROUPS IN THE PRESENCE OF LITHIUM SILANOLATE RHODIA CHIMIE (FR) 2006-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099322-A1 Method of Preparing Polyorganosiloxane With Functional Groups In The Presence of Lithium Silanolate SFXN3, RER1, MSR1 ALDH1A1 1704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.